118 related articles for article (PubMed ID: 29393208)
21. Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial.
Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
Sci Rep; 2015 May; 5():10140. PubMed ID: 25988317
[TBL] [Abstract][Full Text] [Related]
22. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
Heidebrecht F; MacLeod MB; Dawkins L
Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
[TBL] [Abstract][Full Text] [Related]
23. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
Clark CB; Hendricks PS; Lane PS; Trent L; Cropsey KL
Addict Behav; 2014 Dec; 39(12):1736-40. PubMed ID: 25117851
[TBL] [Abstract][Full Text] [Related]
24. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT).
Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
Drug Alcohol Depend; 2016 Aug; 165():143-50. PubMed ID: 27289271
[TBL] [Abstract][Full Text] [Related]
25. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati B; Moula O; Ghachem R
Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
[TBL] [Abstract][Full Text] [Related]
27. Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.
Zhang B; Cai T; Yan Z; Mburu G; Wang B; Yang L
Harm Reduct J; 2016 Feb; 13():8. PubMed ID: 26915361
[TBL] [Abstract][Full Text] [Related]
28. Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi'an, China.
Zhou K; Li H; Wei X; Li X; Zhuang G
J Addict Med; 2017; 11(1):28-33. PubMed ID: 27649264
[TBL] [Abstract][Full Text] [Related]
29. Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies.
Gauthier G; Eibl JK; Marsh DC
Drug Alcohol Depend; 2018 Oct; 191():1-5. PubMed ID: 30064001
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Methadone Treatment in Malaysia: Findings from the Malaysian Methadone Treatment Outcome Study (MyTOS).
Ali N; Aziz SA; Nordin S; Mi NC; Abdullah N; Paranthaman V; Mahmud M; Yee A; Danaee M
Subst Use Misuse; 2018 Jan; 53(2):239-248. PubMed ID: 29116878
[TBL] [Abstract][Full Text] [Related]
31. Self-efficacy and HIV risk behaviors among heroin users in Taiwan.
Ko NY; Wang PW; Wu HC; Yen CN; Hsu ST; Yeh YC; Chung KS; Yen CF
J Stud Alcohol Drugs; 2012 May; 73(3):469-76. PubMed ID: 22456252
[TBL] [Abstract][Full Text] [Related]
32. Perceived barriers to methadone maintenance treatment among Iranian opioid users.
Khazaee-Pool M; Moeeni M; Ponnet K; Fallahi A; Jahangiri L; Pashaei T
Int J Equity Health; 2018 Jun; 17(1):75. PubMed ID: 29890990
[TBL] [Abstract][Full Text] [Related]
33. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
[TBL] [Abstract][Full Text] [Related]
34. Comment on "Methadone Dose Adjustments, Plasma R-Methadone Levels and Therapeutic Outcome of Heroin Users: A Randomized Clinical Trial".
de Bernardis E
Eur Addict Res; 2018; 24(2):88. PubMed ID: 29902789
[No Abstract] [Full Text] [Related]
35. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study.
Cao X; Wu Z; Rou K; Li L; Lin C; Wang C; Luo W; Pang L; Yin W; Li J;
Drug Alcohol Depend; 2014 Dec; 145():87-93. PubMed ID: 25448082
[TBL] [Abstract][Full Text] [Related]
36. Pain management strategies for patients on methadone maintenance therapy: a systematic review of the literature.
Taveros MC; Chuang EJ
BMJ Support Palliat Care; 2017 Dec; 7(4):383-389. PubMed ID: 27566722
[TBL] [Abstract][Full Text] [Related]
37. Methadone treatment of arrestees: A randomized clinical trial.
Schwartz RP; Kelly SM; Mitchell SG; O'Grady KE; Sharma A; Jaffe JH
Drug Alcohol Depend; 2020 Jan; 206():107680. PubMed ID: 31753737
[TBL] [Abstract][Full Text] [Related]
38. Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians.
Roux P; Lions C; Michel L; Cohen J; Mora M; Marcellin F; Spire B; Morel A; Carrieri PM; Karila L;
Curr Pharm Des; 2014; 20(25):4097-105. PubMed ID: 24001291
[TBL] [Abstract][Full Text] [Related]
39. Methadone Medical Maintenance: An Early 21st-Century Perspective.
Novick DM; Salsitz EA; Joseph H; Kreek MJ
J Addict Dis; 2015; 34(2-3):226-37. PubMed ID: 26110221
[TBL] [Abstract][Full Text] [Related]
40. Short term health-related quality of life improvement during opioid agonist treatment.
Nosyk B; Bray JW; Wittenberg E; Aden B; Eggman AA; Weiss RD; Potter J; Ang A; Hser YI; Ling W; Schackman BR
Drug Alcohol Depend; 2015 Dec; 157():121-8. PubMed ID: 26511766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
